This is a Validated Antibody Database (VAD) review about rat Brca2, based on 8 published articles (read how Labome selects the articles), using Brca2 antibody in all methods. It is aimed to help Labome visitors find the most suited Brca2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Brca2 synonym: breast cancer type 2 susceptibility protein homolog; breast cancer 2, early onset; breast cancer 2, mutation 1, University of Wisconsin-Madison; breast cancer susceptibility protein 2; fanconi anemia group D1 protein homolog

Proteintech Group
rabbit polyclonal
  • western blot; human
Proteintech Group Brca2 antibody (Proteintech, 19791-1-AP) was used in western blot on human samples . Mol Cancer (2014) ncbi
EMD Millipore
mouse monoclonal
  • western blot; mouse; 1:10,000; loading ...; fig s11d
EMD Millipore Brca2 antibody (Millipore, OP95-100 ug) was used in western blot on mouse samples at 1:10,000 (fig s11d). Nat Commun (2016) ncbi
mouse monoclonal
  • western blot; human; fig 1
EMD Millipore Brca2 antibody (Millipore, OP95) was used in western blot on human samples (fig 1). Nat Struct Mol Biol (2016) ncbi
mouse monoclonal
  • western blot; human; fig 7h
EMD Millipore Brca2 antibody (Calbiochem, OP95) was used in western blot on human samples (fig 7h). EMBO Rep (2016) ncbi
mouse monoclonal
  • western blot; human; fig 2
EMD Millipore Brca2 antibody (Millipore, OP95) was used in western blot on human samples (fig 2). Oncotarget (2016) ncbi
mouse monoclonal
  • western blot; human; fig 1
In order to analyze G2 checkpoint regulators for hypoxia-induced alterations, EMD Millipore Brca2 antibody (Millipore, OP-95) was used in western blot on human samples (fig 1). Mol Oncol (2016) ncbi
mouse monoclonal
  • western blot; human; fig s11
EMD Millipore Brca2 antibody (Calbiochem, OP95) was used in western blot on human samples (fig s11). PLoS Genet (2015) ncbi
mouse monoclonal
  • immunocytochemistry; human; fig 3
EMD Millipore Brca2 antibody (Calbiochem, OP95-100UG) was used in immunocytochemistry on human samples (fig 3). PLoS Pathog (2014) ncbi
Articles Reviewed
  1. Bahal R, Ali McNeer N, Quijano E, Liu Y, Sulkowski P, Turchick A, et al. In vivo correction of anaemia in ?-thalassemic mice by ?PNA-mediated gene editing with nanoparticle delivery. Nat Commun. 2016;7:13304 pubmed publisher
  2. Michl J, Zimmer J, Buffa F, McDermott U, Tarsounas M. FANCD2 limits replication stress and genome instability in cells lacking BRCA2. Nat Struct Mol Biol. 2016;23:755-757 pubmed publisher
  3. Choe K, Nicolae C, Constantin D, Imamura Kawasawa Y, Delgado Diaz M, De S, et al. HUWE1 interacts with PCNA to alleviate replication stress. EMBO Rep. 2016;17:874-86 pubmed publisher
  4. De Toni E, Ziesch A, Rizzani A, Török H, Hocke S, Lü S, et al. Inactivation of BRCA2 in human cancer cells identifies a subset of tumors with enhanced sensitivity towards death receptor-mediated apoptosis. Oncotarget. 2016;7:9477-90 pubmed publisher
  5. Hasvold G, Lund Andersen C, Lando M, Patzke S, Hauge S, Suo Z, et al. Hypoxia-induced alterations of G2 checkpoint regulators. Mol Oncol. 2016;10:764-73 pubmed publisher
  6. Castella M, Jacquemont C, Thompson E, Yeo J, Cheung R, Huang J, et al. FANCI Regulates Recruitment of the FA Core Complex at Sites of DNA Damage Independently of FANCD2. PLoS Genet. 2015;11:e1005563 pubmed publisher
  7. Sowd G, Mody D, Eggold J, Cortez D, Friedman K, Fanning E. SV40 utilizes ATM kinase activity to prevent non-homologous end joining of broken viral DNA replication products. PLoS Pathog. 2014;10:e1004536 pubmed publisher
  8. Wang Y, Wang Z, Qi Z, Yin S, Zhang N, Liu Y, et al. The negative interplay between Aurora A/B and BRCA1/2 controls cancer cell growth and tumorigenesis via distinct regulation of cell cycle progression, cytokinesis, and tetraploidy. Mol Cancer. 2014;13:94 pubmed publisher